A joint research team from HKUMed and HKUST has demonstrated that ZCB11, a broadly neutralizing antibody derived from a local mRNA-vaccinee, shows pot...Read more

Surface contact with virus is ubiquitous in the transmission pathways of respiratory diseases such as Coronavirus Disease 2019 (COVID-19), by which co...Read more

The replication and pathogenicity of SARS-CoV-2 Omicron BA.2 are comparable to that of BA.1 in experimental animal models. However, BA.2 has rapidly e...Read more

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.2 was a dominant circulating SARS-CoV-2 variant worldwide. Recent reports hint...Read more

SARS-CoV-2 has been confirmed in over 450 million confirmed cases since 2019. Although several vaccines have been certified by the WHO and people are ...Read more

The emergence of SARS-CoV-2 variants of concern and repeated outbreaks of coronavirus epidemics in the past two decades emphasize the need for next-ge...Read more

The Omicron (B.1.1.529) variant of SARS-CoV-2 emerged in November 2021 and is rapidly spreading among the human population1. Although recent reports r...Read more

The Coronavirus Disease 2019 (COVID-19) pandemic is unlikely to abate until sufficient herd immunity is built up by either natural infection or vaccin...Read more

Background: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is believed to be mostly transm...Read more

Background: Coronavirus disease 2019 (COVID-19) is primarily an acute respiratory tract infection. Distinctively, a substantial proportion of COVID-19...Read more

Background: A physiological small animal model that resembles COVID-19 with low mortality is lacking. Methods: Molecular docking on the binding betwe...Read more

Researchers from the University of Hong Kong and the Chinese Academy of Sciences have conducted a study on SARS-CoV-2 infection of human neural progen...Read more

香港大學微生物學系講座教授袁國勇領導的團隊發現，冠狀病毒感染會導致細胞凋亡，關鍵在於感染後激發「蛋白激酶R樣內質網激酶」。抑制劑可用於治療病毒性肺炎，抑制過度炎症反應，將成為未來抗病毒治療的方向。該團隊使用中東呼吸綜合症冠狀病毒感染人類支氣管上皮細胞進行研究，發現病毒產生的膜蛋白與GRP78蛋白質結...Read more

Background Clinical outcomes of the interaction between the co-circulating pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and s...Read more

新型冠狀病毒已經感染了超過160萬人，並在全球造成了超過10,000人死亡。香港大學的研究人員發現，該病毒可以在兩天內在人體細胞中複製超過100次，使其比SARS更具傳染性。該病毒還可以抑制人體的免疫反應，導致無症狀的攜帶者不知不覺地傳播病毒。研究人員建議在治療中使用干擾素作為關鍵組成部分。...

In this article the author name Kwok-Yung Yuen was incorrectly written as Kwok-Yong Yuen. The original article has been corrected....

Omicron was designated by the WHO as a VOC on 26 November 2021, only 4 days after its sequence was first submitted. However, the impact of Omicron on ...Read more